Navigation Links
Human Genome Sciences Announces Positive Final Results Of Phase 2b,Trial of Albuferon

response offered by the 1200-microgram dose on a two-week administration schedule," said Dr. Stump.

    Albuferon 1200-mcg Monthly (Albuferon 1200 Q4w)


    -- ITT analysis shows that 50.9% of patients in the Albuferon 1200 Q4w

       treatment group achieved SVR, vs. 57.9% for Pegasys administered every

       week.

    -- In heavier patients (>75 kg) who were treatment-adherent, 61.0% of

       those in the Albuferon 1200 Q4w treatment group achieved SVR, versus

       53.3% for Pegasys administered once every week.

    -- Among all treatment-adherent patients in the Albuferon 1200 Q4w

       treatment group, 62.0% achieved SVR, versus 66.7% for Pegasys.

    -- The rate of discontinuations due to adverse events was 12.1% in the

       Albuferon 1200 Q4w treatment group, vs. 6.1% in the Pegasys group.

    -- The number of patients experiencing severe hematologic adverse events

       was significantly lower in the Albuferon 1200 Q4w treatment group

       (10.3%, vs. 23.7% for Pegasys, p=0.006).

"We are encouraged that more than half of the patients achieved sustained virologic response in the treatment group receiving Albuferon 1200-mcg once every month," said Dr. Stump. "These data, along with emerging Phase 2 data for a monthly 1500-mcg dose, provide an excellent rationale for the study that we and our collaborator, Novartis, are currently planning to evaluate higher doses of Albuferon administered monthly."

The top-line final Phase 2b results include data through Week 24 following completion of 48 weeks of therapy. The open-label, multi-center, active- controlled, dose-ranging trial enrolled and randomized 458 patients with genotype 1 chronic hepatitis C. Patients were randomized into four treatment groups, three of which received subcutaneously administered Albuferon (900 mcg every two weeks, 1200 mcg every two weeks, and 1200 mcg every four weeks). The fourth treatment group served as the active control group and recei
'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Testing for Human Papillomavirus
2. Bio-Matrix Scientifics Dr. ONeill Sees University of Pittsburghs Published Study on Culture Blood-Forming Stem Cells from Human Fat Tissue as Supporting Near Term Benefits of Banking Adipose (Fat) Derived Stem Cells
3. Phase II Results Show Once-Daily Dosing of Human GLP-1 Analog Liraglutide, Brings Patients to A1c Target
4. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
5. Modigene Announces Successful Completion of Pharmacokinetic & Pharmacodynamic Pre-Clinical Experiments for Proprietary Long-Acting Human Growth Hormone, Long-acting Interferon Beta and Long-acting Erythropoietin
6. Second Successful Quigley QR-443 Study Suggests Method of Action Relevant to Broad Range of Chronic Inflammatory Diseases - Human Study to Follow -
7. Research Documents Scalable Production, Survival Following Engraftment and Positive Impact on Cardiac Function in Infarcted Rats for Gerons Human Embryonic Stem Cell-Based Therapeutic for Heart Failure
8. Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B Showed Significant Reductions in Disease Activity in Patients with Active Systemic Lupus Erythematosus
9. NCI Researchers Discover Genes That Are Turned on at High Levels in Tumor-associated Blood Vessels of Mice and Humans
10. Research Indicates Gerons Human Embryonic Stem Cell-Based Therapeutic for Spinal Cord Injury Evades Direct Attack by the Human Immune System
11. Mymetics HIV Vaccine Demonstrates First-Ever Production of Neutralizing IgA Antibodies in Non-Human Primate Model
Post Your Comments:
(Date:9/23/2014)... 23, 2014  The objective of this market insight ... and research facilities across North America ... study carries out an assessment of the current and ... and law enforcement forensics labs. It also provides a ... PPE segments, and safety regulations specific to labs and ...
(Date:9/23/2014)... PARIS , September 23, 2014 /PRNewswire/ ... tels que l,automobile, la santé, le ferroviaire ... en plus connectées, donneront progressivement accès à ... issues des nombreux capteurs installés au cœur ... estime à plusieurs dizaines de milliards le ...
(Date:9/23/2014)... Sept. 23, 2014 Research and ... "Physician Office Laboratory Markets, 3rd Edition" ... report, Physician Office Laboratory Markets is Kalorama,s complete ... industry. Physician office laboratories are diverse in their ... reimbursable, in-office pregnancy and glucose tests. Some specialty ...
Breaking Medicine Technology:Personal Protective Equipment (PPE) Outlook for the North American and Western European Labs and Research Facilities 2Personal Protective Equipment (PPE) Outlook for the North American and Western European Labs and Research Facilities 3Altran transforme le big data du monde industriel en nouveau business 2Physician Office Laboratory Markets, 3rd Edition 2Physician Office Laboratory Markets, 3rd Edition 3
(Date:9/23/2014)... (PRWEB) September 23, 2014 Oaksterdam University ... Today . In its first post, the University addresses ... and changing cannabis industry. , The cannabis industry is ... alone is expecting an 18-month boost of more than ... adult use pot sales. And, the new legal recreational ...
(Date:9/23/2014)... NIH TO CONVENE PATHWAYS TO PREVENTION WORKSHOP: ROLE OF ... WHAT: , The National Institutes of Health is ... available scientific evidence on the long-term effectiveness and potential ... be among the nation,s top experts in the field ... as well as key NIH scientists who focus on ...
(Date:9/23/2014)... 2014 As a consumer in today’s ... purchase. It’s difficult to trust testimonials that are supplied ... to manipulate their customers into saying anything. , Consumer ... tend to lack in depth coverage on a particular ... founded to fix this issue and focus on exposing ...
(Date:9/23/2014)... Sept. 23, 2014 (HealthDay News) -- Both drinking and ... factors for alcohol abuse by high school students, a ... survey of high school students who drink, could help ... who already drink, to stop them from becoming binge ... between age of first alcohol use and progression to ...
(Date:9/23/2014)... 23, 2014 What: Rutgers Presbyterian ... West Side that embodies the inclusion and diversity ... Scripture and the Ecological Crisis, a public lecture ... Professor Emerita of Old Testament at Louisville Presbyterian ... wisdom that lends insight into current ecological problems, ...
Breaking Medicine News(10 mins):Health News:Oaksterdam University Addresses "Why Quality Training Matters in a Growing Marijuana Industry" in First Blog Post 2Health News:Oaksterdam University Addresses "Why Quality Training Matters in a Growing Marijuana Industry" in First Blog Post 3Health News:NIH Pathways to Prevention Workshop: The Role of Opioids in the Treatment of Chronic Pain 2Health News:NIH Pathways to Prevention Workshop: The Role of Opioids in the Treatment of Chronic Pain 3Health News:Consumer Health Reports Debuts Revolutionary Review Website 2Health News:Younger Age at First Drink, Higher Odds for Problem Drinking: Study 2Health News:Younger Age at First Drink, Higher Odds for Problem Drinking: Study 3Health News:Inhabiting Eden: Christians, Scripture, and the Ecological Crisis – Public Lecture to Discuss Faith-Based Environmentalism 2
... Annual and Special Meeting web cast live, LAVAL, ... Special,meeting of Neurochem Inc. (NASDAQ: NRMX ; TSX: ... new name, BELLUS Health Inc., which,it expects to start ... stock,ticker symbols (NASDAQ: BLUS ; TSX: BLU). Neurochem ...
... 15 Heritage Pharma Ltd.,(U.K.) and its wholly ... the Company has consummated the,private placement of Series ... capital investors McClendon Venture Company, LLC and,TLW Venture ... prior to fees,and expenses. The proceeds will be ...
... a high frequency of sleep-related breathing disorders (SRBD) in ... an overnight sleep test, especially in patients with underlying ... April 15 issue of the Journal of Clinical Sleep ... MD, of Johns Hopkins University and Bayview Medical Center ...
... Allergies and asthma affect,six times more Americans than ... America. As the fifth leading chronic disease, allergies,along ... Americans., (Photo: http://www.newscom.com/cgi-bin/prnh/20080415/NYTUFNS1 ), ... to prevent or treat,allergies and asthma," said Peggy ...
... therapy shows promise against pancreatic tumors, scientists say , , ... drug duo might help prevent colorectal cancer, and the ... of liver cancer. , So conclude two studies presented ... meeting in San Diego. , In the first report, ...
... Position Company to Meet Strategic ... Growth Objectives, ... global full-service clinical research organization, today,announced the promotion of Simon S. ... as President and Chief Operating,Officer, will continue as Chief Operating Officer. ...
Cached Medicine News:Health News:At Annual and Special Meeting of Shareholders - Neurochem to officially adopt new name - BELLUS Health - And to provide update on programs including first new natural health product, VIVIMIND(TM) 2Health News:At Annual and Special Meeting of Shareholders - Neurochem to officially adopt new name - BELLUS Health - And to provide update on programs including first new natural health product, VIVIMIND(TM) 3Health News:At Annual and Special Meeting of Shareholders - Neurochem to officially adopt new name - BELLUS Health - And to provide update on programs including first new natural health product, VIVIMIND(TM) 4Health News:At Annual and Special Meeting of Shareholders - Neurochem to officially adopt new name - BELLUS Health - And to provide update on programs including first new natural health product, VIVIMIND(TM) 5Health News:At Annual and Special Meeting of Shareholders - Neurochem to officially adopt new name - BELLUS Health - And to provide update on programs including first new natural health product, VIVIMIND(TM) 6Health News:Heritage Announces $10 Million Financing 2Health News:JCSM: A high frequency of sleep-related breathing disorders in hospitalized patients 2Health News:Figure Skater Peggy Fleming Teams With HealthSaver: Allergies and Asthma Relief 2Health News:Figure Skater Peggy Fleming Teams With HealthSaver: Allergies and Asthma Relief 3Health News:Figure Skater Peggy Fleming Teams With HealthSaver: Allergies and Asthma Relief 4Health News:Figure Skater Peggy Fleming Teams With HealthSaver: Allergies and Asthma Relief 5Health News:Figure Skater Peggy Fleming Teams With HealthSaver: Allergies and Asthma Relief 6Health News:New Treatments Help Fight Liver, Colon Cancer 2Health News:New Treatments Help Fight Liver, Colon Cancer 3Health News:New Treatments Help Fight Liver, Colon Cancer 4Health News:Kendle Promotes Simon S. Higginbotham to President; Appoints Alan J. Boyce as Chief Marketing Officer 2Health News:Kendle Promotes Simon S. Higginbotham to President; Appoints Alan J. Boyce as Chief Marketing Officer 3
Indicated for procedures of the wrist, ankle, elbow, and other small joints, the,UltrAblator is effective for ablation of soft tissue and coagulation of bleeders,encountered during surgery....
... This implant is designed to replace the ... on the distal pole which fits under a ... bone, and a suture hole on the proximal ... anatomical position during the early postoperative period until ...
... has the same anatomical configuration as the ... to provide for stability. The implant has ... use in suture fixation through the scaphoid ... while a capsuloligamentous system forms around the ...
... for four corner fusion of the capitate, ... hand. The plate is intended for use ... of function due to SLAC and SNAC ... rheumatoid arthritis. When combined with the specially ...
Medicine Products: